Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OSCR Stock Forecast 2025-2026
$16.77
Current Price
$4.83B
Market Cap
Buy 1
Hold 3
Sell 5
Wall St Analyst Ratings
Distance to OSCR Price Targets
+49.1%
To High Target of $25.00
-25.5%
To Median Target of $12.50
-34.4%
To Low Target of $11.00
OSCR Price Momentum
-6.7%
1 Week Change
-5.4%
1 Month Change
+7.4%
1 Year Change
+24.8%
Year-to-Date Change
-29.5%
From 52W High of $23.80
+49.7%
From 52W Low of $11.20
📊 TOP ANALYST CALLS
Did OSCR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Oscar Health is one of their latest high-conviction picks.
Latest OSCR Stock Price Targets & Analyst Predictions
Based on our analysis of 15 Wall Street analysts, OSCR has a bearish consensus with a median price target of $12.50 (ranging from $11.00 to $25.00). The overall analyst rating is Hold (4.4/10). Currently trading at $16.77, the median forecast implies a -25.5% downside. This outlook is supported by 1 Buy, 3 Hold, and 5 Sell ratings.
The most optimistic forecast comes from Jessica Tassan at Piper Sandler, projecting a 49.1% upside. Conversely, the most conservative target is provided by Stephen Baxter at Wells Fargo, suggesting a 34.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OSCR Analyst Ratings
1
Buy
3
Hold
5
Sell
OSCR Price Target Range
Low
$11.00
Average
$12.50
High
$25.00
Current: $16.77
Latest OSCR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OSCR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 26, 2025 | Piper Sandler | Jessica Tassan | Overweight | Upgrade | $25.00 |
| Nov 13, 2025 | Wells Fargo | Stephen Baxter | Underweight | Maintains | $11.00 |
| Nov 10, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $13.00 |
| Nov 7, 2025 | UBS | Jonathan Yong | Sell | Maintains | $12.00 |
| Oct 14, 2025 | Goldman Sachs | Scott Fidel | Neutral | Initiates | $17.00 |
| Oct 7, 2025 | Wells Fargo | Stephen Baxter | Underweight | Maintains | $14.00 |
| Aug 14, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $13.00 |
| Jul 25, 2025 | Baird | Michael Ha | Neutral | Downgrade | $14.00 |
| Jul 23, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $11.00 |
| Jul 15, 2025 | UBS | Jonathan Yong | Sell | Downgrade | $11.00 |
| Jul 11, 2025 | Wells Fargo | Stephen Baxter | Underweight | Downgrade | $10.00 |
| Jul 2, 2025 | Barclays | Andrew Mok | Underweight | Initiates | $17.00 |
| Jun 9, 2025 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $18.00 |
| Mar 13, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Downgrade | $16.00 |
| Dec 10, 2024 | Jefferies | David Windley | Underperform | Initiates | $12.00 |
| Nov 6, 2024 | B of A Securities | Adam Ron | Underperform | Downgrade | $13.50 |
| Oct 7, 2024 | UBS | Jonathan Yong | Neutral | Initiates | $23.00 |
| Sep 10, 2024 | Piper Sandler | Jessica Tassan | Overweight | Reiterates | $28.00 |
| Aug 8, 2024 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $28.00 |
| Jul 10, 2024 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $25.00 |
Oscar Health, Inc. (OSCR) Competitors
The following stocks are similar to Oscar Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
OSCR
Oscar Health
mkt cap
4.83B
Oscar Health, Inc. (OSCR) Financial Data
Oscar Health, Inc. has a market capitalization of $4.83B with a P/E ratio of 34.6x. The company generates $11.29B in trailing twelve-month revenue with a -2.2% profit margin.
Revenue growth is +23.2% quarter-over-quarter, while maintaining an operating margin of -4.3% and return on equity of -22.2%.
Valuation Metrics
Market Cap
$4.83B
Enterprise Value
$2.14B
P/E Ratio
34.6x
PEG Ratio
0.2x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+23.2%
Gross Margin
N/A
Operating Margin
-4.3%
Net Margin
-2.2%
EPS Growth
+23.2%
Financial Health
Cash/Price Ratio
+68.5%
Current Ratio
0.9x
Debt/Equity
72.3x
ROE
-22.2%
ROA
-2.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Oscar Health, Inc. (OSCR) Business Model
About Oscar Health, Inc.
What They Do
Technology-driven health insurance company.
Business Model
Oscar Health offers individual and family health insurance plans, generating revenue through premium collections. The company utilizes technology to enhance healthcare experiences, improve care coordination, and facilitate patient engagement, aiming to attract and retain customers with accessible and personalized services.
Additional Information
Oscar Health integrates telemedicine, transparent pricing, and personalized care navigation into its offerings. As of late 2025, the company has a significant market capitalization in the multi-billion euro range, indicating a strong presence in the competitive health insurance sector.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
2,400
CEO
Mr. Mark Thomas Bertolini
Country
United States
IPO Year
2021
Website
www.hioscar.comOscar Health, Inc. (OSCR) Latest News & Analysis
Latest News
Quick Summary
Oscar Health is experiencing challenges in 2025, with a potential return to profitability expected in 2026, which may impact investor perceptions of the stock's current value.
Why It Matters
Oscar Health's current undervaluation may present a buying opportunity as it anticipates a return to profitability in 2026, potentially leading to significant gains.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Oscar Health (OSCR) shares rose following an upgrade from Piper Sandler analysts, marking a significant gain for the health insurer.
Why It Matters
The upgrade by Piper Sandler signals increased confidence in Oscar Health's growth potential, likely attracting more investors and driving share prices higher.
Source: Investopedia
Market Sentiment:
Positive
Quick Summary
The company anticipates its 2026 AI revenue guidance will exceed 100% year-over-year growth.
Why It Matters
Strong AI revenue growth projections signal robust demand and potential market leadership, likely boosting investor confidence and stock performance.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Quick Summary
Health insurance stocks increased ahead of Thanksgiving, fueled by optimism over potential agreement between the Trump administration and Congress on extending ACA tax credits for individual coverage.
Why It Matters
Rising health insurance stocks indicate investor optimism about potential tax credit extensions, which could boost demand for individual coverage and enhance profitability for insurers.
Source: Forbes
Market Sentiment:
Positive
Quick Summary
A fund sold 153,753 shares of Oscar Health for $10.47 million, reducing its stake to 2,856,025 shares valued at $54.06 million, which remains 17.06% of its AUM.
Why It Matters
A significant sale of Oscar Health shares by a major fund indicates potential shifts in confidence, impacting stock perception and future performance, crucial for investors' strategies.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Oscar Health Inc (NYSE: OSCR) surged 25% after reports of a White House plan to extend ACA subsidies for two years, introducing new income caps and minimum premium payments.
Why It Matters
Oscar Health's 25% surge indicates strong investor confidence due to potential ACA subsidy extensions, which could boost enrollment and revenue, enhancing the company's market position.
Source: Invezz
Market Sentiment:
Neutral
Frequently Asked Questions About OSCR Stock
What is Oscar Health, Inc.'s (OSCR) stock forecast for 2026?
Based on our analysis of 15 Wall Street analysts, Oscar Health, Inc. (OSCR) has a median price target of $12.50. The highest price target is $25.00 and the lowest is $11.00.
Is OSCR stock a good investment in 2026?
According to current analyst ratings, OSCR has 1 Buy ratings, 3 Hold ratings, and 5 Sell ratings. The stock is currently trading at $16.77. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OSCR stock?
Wall Street analysts predict OSCR stock could reach $12.50 in the next 12 months. This represents a -25.5% decrease from the current price of $16.77. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Oscar Health, Inc.'s business model?
Oscar Health offers individual and family health insurance plans, generating revenue through premium collections. The company utilizes technology to enhance healthcare experiences, improve care coordination, and facilitate patient engagement, aiming to attract and retain customers with accessible and personalized services.
What is the highest forecasted price for OSCR Oscar Health, Inc.?
The highest price target for OSCR is $25.00 from Jessica Tassan at Piper Sandler, which represents a 49.1% increase from the current price of $16.77.
What is the lowest forecasted price for OSCR Oscar Health, Inc.?
The lowest price target for OSCR is $11.00 from Stephen Baxter at Wells Fargo, which represents a -34.4% decrease from the current price of $16.77.
What is the overall OSCR consensus from analysts for Oscar Health, Inc.?
The overall analyst consensus for OSCR is bearish. Out of 15 Wall Street analysts, 1 rate it as Buy, 3 as Hold, and 5 as Sell, with a median price target of $12.50.
How accurate are OSCR stock price projections?
Stock price projections, including those for Oscar Health, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 2:25 AM UTC